GlaxoSmithKline

World's largest malaria vaccine trial now underway in 7 African countries.
NewsRx Health & Science; 11/22/2009; 1863 words; ...the disease. A vaccine would complement existing interventions, such as bed nets and effective drug therapies. GlaxoSmithKline Biologicals' (GSK Bio) RTS,S is the first malaria vaccine candidate to demonstrate significant efficacy during...

Antigenics Provides Details On GlaxoSmithKline's Pivotal Malaria Vaccine Trial With QS-21 Adjuvant.
Pediatrics Week; 11/21/2009; 1069 words; ...Inc. (NASDAQ: AGEN) today indicated that GlaxoSmithKline's (GSK) Phase III malaria vaccine clinical...Serv, Biotechnology, Clinical Trial Research, GlaxoSmithKline, Immunization, Malaria, Malaria Vaccines...

This Global Outlook Series on Genetic Engineering Provides a Collection of Market Briefs and Concise Summaries of Research Findings.
Gene Therapy Weekly; 11/19/2009; 1522 words; ...Nanobac Pharmaceuticals to Take Over DNAPrint Genomics GlaxoSmithKline to Take Over Genelabs Technologies Invitrogen Merges with...AmerisourceBergen Announces Acquisition of IgG of America GlaxoSmithKline Plans Praecis Acquisition RECENT INDUSTRY ACTIVITY Eureka...

Ligand's JAK3 Research Collaboration Extended by Pfizer.
Blood Weekly; 11/19/2009; 1329 words; ...with major pharmaceutical and biotechnology companies, including Bristol-Myers Squibb, Celgene, Cephalon, GlaxoSmithKline, Schering-Plough, Pfizer and Wyeth Pharmaceuticals (now Pfizer). With nine pharmaceutical agreements and...

NasVax Announces Positive Results from Preclinical Testing of Swine Flu Vaccine using its Novel Adjuvant.
Vaccine Weekly; 11/18/2009; 697 words; ...pneumococcal vaccines. Antigens in this project are the focus of a Research and Option-for-License Agreement with GlaxoSmithKline. The BBS1 products are immunotherapeutics for Alzheimer's disease, both as a monoclonal antibody (MAb) and...